What is ConcertoCare?
ConcertoCare operates as a leading risk-bearing provider, specializing in the delivery of multidisciplinary, field-based care for complex patient populations. By meeting patients directly in their homes or clinical settings, the organization effectively bridges the gap between traditional healthcare delivery and the specific needs of high-risk individuals. The company's proprietary care model is engineered to improve health outcomes while simultaneously lowering the total cost of care, a critical objective in the current value-based healthcare landscape. Through its integrated approach, ConcertoCare has proven its efficacy in reducing hospital admissions by 47% and readmissions by 40%, positioning itself as an essential partner for health systems seeking to optimize care for their most challenging cohorts.
How much funding has ConcertoCare raised?
ConcertoCare has raised a total of $188.1M across 6 funding rounds:
Private Equity
$15.4M
Debt
$7.2M
Debt
$15.2M
Private Equity
$15.2M
Private Equity
$30M
Series B
$105M
Private Equity (2012): $15.4M, investors not publicly disclosed
Debt (2013): $7.2M, investors not publicly disclosed
Debt (2013): $15.2M, investors not publicly disclosed
Private Equity (2015): $15.2M, investors not publicly disclosed
Private Equity (2016): $30M backed by Arboretum Ventures and Deerfield Management Company
Series B (2022): $105M with participation from SteelSky Ventures, Pennington Partners, Wells Fargo Capital Finance, Vast Ventures, Deerfield, Charles and Lynn Schusterman Family Foundation, and The Obvious
Key Investors in ConcertoCare
Deerfield Management Company
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy, supporting companies across the ecosystem with flexible funding models.
SteelSky Ventures
SteelSky Ventures is a visionary venture fund focused on investing in companies that enhance access, care, and outcomes in women's health and digital health infrastructure.
Arboretum Ventures
Arboretum Ventures is a Midwest-based healthcare venture capital firm with over 20 years of experience in investing in innovative healthcare solutions and tech-enabled care delivery.
What's next for ConcertoCare?
With the recent influx of capital, ConcertoCare is well-positioned to expand its operational footprint and enhance its technological infrastructure. The strategic focus will likely center on scaling its multidisciplinary care teams and deepening its integration with existing provider networks to drive further efficiencies. As the healthcare industry continues to shift toward value-based reimbursement models, ConcertoCare's proven track record in managing complex, high-cost populations provides a significant competitive advantage. Future initiatives will likely involve leveraging advanced data analytics to refine patient risk stratification and further personalize care delivery, ensuring the company remains at the forefront of the digital health and complex care management sectors.
See full ConcertoCare company page
